Partner Content Partner Content PRIYSM ID boosts customer service offer with new customer ex... PRISYM ID BOOSTS CUSTOMER SERVICE OFFER
News Private equity firms play 'pass the Parexel' with $8.5bn han... Four years after being taken private, Parexel has been sold again, with Goldman Sachs' private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisatio
R&D Pharmacy and clinical research: the pharmaphorum podcast In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.
Digital Blockchain: Ready to revolutionise medicinal cannabis resear... Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical cannabis and oth
Partner Content Partner Content COUCH Health Engages Mark Duman as Chief Strategy Officer COUCH Health, a patient engagement agency, announced the appointment of Mark Duman as its Chief Strategy Officer (CSO).
News Kelun's MSD-partnered TROP2 drug gets first okay in China Kelun-Biotech has become the second drugmaker to bring a TROP2 ADC to regulatory approval, after its sac-TMT drug was cleared in China
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
